Creative Destruction Lab Health Stream: How Healthtech and Life Science Founders Can Prepare
The Creative Destruction Lab Health Stream supports founders commercialising technologies that could improve the prevention, diagnosis or treatment of medical conditions and improve the efficiency of healthcare delivery.
CDL Health works with experienced doctors, scientists, engineers, operators, entrepreneurs and investors to help founders translate technical innovation into commercially viable companies.
The programme does not charge participation fees and does not take equity.
What Types of Health Companies Can Apply?
The stream is particularly relevant for technically differentiated healthcare businesses.
CDL says suitable companies may be working to improve the quality, speed, cost or accessibility of healthcare.
The programme accepts early venture and growth-stage companies, and even some pre-incorporation projects, although founders should generally have a prototype or meaningful early technical validation.
Health-related CDL specialisations currently include biomedical engineering, cancer, computational health, health and wellness, healthcare robotics and neurotechnology.
CDL Health itself is also offered through Berlin and Doha.
What Happens During CDL Health?
Accepted founders attend up to five objective-setting sessions.
Mentors help teams identify the most important near-term milestones, whether those involve product validation, clinical evidence, regulation, partnerships, fundraising or commercialisation.
Founders then execute against the objectives between sessions.
This structure is particularly useful in healthcare because the route from promising technology to widespread clinical adoption can be long and complicated.
Is CDL Health Funded?
There is no automatic cash investment.
Instead, founders receive access to mentors, scientists and investors without paying a programme fee or surrendering equity.
This can make CDL particularly attractive to founders who want to strengthen commercial readiness before negotiating a major financing round.
How Should Health Founders Prepare?
A strong application should clearly separate scientific evidence from commercial assumptions.
Explain what has already been demonstrated in the lab or clinic and what still needs to be proven.
Describe regulatory pathways where relevant.
Founders should also demonstrate a realistic understanding of who purchases the product. The doctor using a technology is not always the organisation paying for it.
Hospitals, insurers, health systems, laboratories, governments and patients may have very different incentives.
Current Application Status
The 2026/27 general CDL application deadline was July 24, 2026, and the central application portal now says applications are closed.
Creative Destruction Lab Quantum Stream: Application Guide for Quantum Startups
Quantum founders face a particularly difficult commercial challenge.
The science may be revolutionary, but customers, applications and scalable business models can take years to emerge.
The CDL Quantum Stream brings together entrepreneurs, scientists and investors to help research-driven founders identify realistic commercial paths for quantum technologies.
Current CDL Quantum locations include Montreal, San Sebastian and Toronto.
What Is CDL Quantum?
CDL Quantum supports companies developing technologies connected to quantum computing and related areas.
Companies receive access to scientific experts as well as experienced founders, operators and investors.
The objective is not simply to discuss the science.
Mentors help companies prioritise the commercial and technical milestones required to reduce risk and move towards viable markets.
CDL highlights alumni including quantum technology company Xanadu, whose founder has credited CDL with helping the team define milestones that reduced risk ahead of its early financing.
Who Is a Good Fit?
Founders should have genuine technical differentiation.
This may involve quantum hardware, algorithms, software, sensing, communications, enabling technologies or adjacent infrastructure.
Because quantum markets are still developing, founders need to explain both the technology and the timing.
Why does this company need to exist now?
Which customers have a problem that the technology can realistically solve in the foreseeable future?
Applications that depend entirely on hypothetical future quantum capabilities may be more difficult to commercialise than companies with staged routes to revenue.
Does CDL Quantum Take Equity?
No.
Like other CDL programmes, CDL Quantum is operated within a nonprofit model and does not require founders to surrender equity simply for participating.
It also does not automatically invest startup capital.
Founders may nevertheless meet investors through CDL’s mentor network.
What Was the 2026/27 Deadline?
The central CDL application page states that general applications closed on July 24, 2026.
Quantum had an earlier special deadline: CDL Quantum Bootcamp applications closed June 21, 2026.
The 2026/27 cycle is therefore closed.
Founders should monitor CDL for the next programme-year announcement rather than relying on stream pages that still contain outdated open-application messaging.
How to Prepare for the Next CDL Quantum Cycle
Use the waiting period to develop technical evidence and sharpen the commercial story.
Identify measurable performance advantages.
Explain the intellectual property.
Show which part of the technology has already been demonstrated.
Most importantly, identify the customer problem independently of the excitement surrounding quantum technology.
An investor or mentor should understand the business opportunity even if they are not a quantum physicist.
Visit the Creative Destruction Lab Quantum Stream page
For a technically strong quantum team, CDL can provide something particularly valuable: a structured environment where scientific ambition is constantly tested against commercial reality.